DGAP-DD: Biotest AG english

 | Source: EQS Group AG EQS Group AG 


Notification concerning transactions by persons performing managerial
responsibilities pursuant to section 15a of the WpHG

Directors' Dealings notification transmitted by DGAP - a company of EquityStory AG.
The person with duty of notification is solely responsible for the content
of this announcement.
------------------------------------------------------------------------------

Details of the person subject to the disclosure requirement
Last name: Dr. Reinecke
First name: Martin
Company: Biotest AG

Position: Seniour Vice President Plasma Alliances and Protein Supply

Information about the transaction with duty of notification

Description of the financial instrument: Preference Shares
ISIN/WKN of the financial instrument: DE0005227235
Type of transaction: Purchase
Date: 06.05.2010
Price: 31.00
Currency: EUR
No. of items: 250
Total amount traded: 7750.00
Place: Xetra

Information about the company with duty of publication

Issuer: Biotest AG
Landsteinerstraße 5
63303 Dreieich
Deutschland
ISIN: DE0005227235
WKN: 522723


End of Directors' Dealings Notification (c) DGAP 10.05.2010 

Ad hoc announcement, Financial News and Media Release distributed by DGAP.
Media archive at www.dgap-medientreff.de and www.dgap.de
ID 11283
GlobeNewswire